December 10, 2015 | Israeli agricultural biotechnology company Evogene is partnering with chemicals giant BASF to develop new herbicides. Under the three-year cooperation agreement, Evogene will use its genetic-screening platform to identify new chemicals potentially useful as herbicides. Compounds that successfully pass the screening will continue in BASF’s development process, and if such chemicals are brought to market, it is believed that Evogene will receive royalty payments. Founded in 2002 and run by CEO Ofer Haviv, Evogene already has agreements with large agricultural and biotech companies companies such as Monsanto, Syngenta, and Bayer.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments